Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05835479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 3, 2025 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 3 of 6 sitesv4
  2. Primary completion date: Oct 2024 to May 2025
    • Study sites: 4 to 6
    • Study completion date: Dec 2024 to Aug 2025
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Study sites: 0 to 4
    • Primary completion date: Aug 2024 to Oct 2024
    • Study completion date: Sep 2024 to Dec 2024
    • Start date changed from estimate of Oct 2023 to Nov 14, 2023
    • Study description shortened, about 6 words
    • Eligibility criteria expanded, about 2 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to generate clinical data on the efficacy, safety, and tolerability of rezafungin combined with 7 days of co-trimoxazole for treatment of Pneumocystis pneumonia (PCP) in adults living with human immunodeficiency virus (HIV), which would expand the knowledge of clinical use of rezafungin.
Trial Details
NCT Number NCT05835479
Lead Sponsor Mundipharma Research Limited
Conditions
(from sponsor)		 Pneumocystis Pneumonia
Related terms Pneumonia, Pneumocystis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov